Coeliac disease related to diabetes
22 March, 2010 by Staff WritersAn international research team has identified new gene variants associated with gluten intolerance.
Positive results for Specialised Therapeutics Australia in lung cancer trial
18 March, 2010 by Tim DeanPhase III trial shows breast cancer drug, Abraxane, effective against lung cancer.
Personalised medicine advanced with TGA approval of bowel cancer treatment
10 March, 2010 by Tim DeanMetastatic bowel cancer treatment, Erbitux, is one of the new generation of highly effective personalised medicine therapies.
Diabetes market growing, obesity market shrinking: analysts
10 March, 2010 by Tim DeanDatamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.
Link found between Hepatitis C and diabetes
09 March, 2010 by Staff WritersResearchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes.
Feature: Appetite for NPY
01 March, 2010 by Tim DeanA better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.
Epilepsy, aging and malaria research big winners in 2010 NHMRC grants
25 February, 2010 by Staff Writers$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering.
Patrys granted key patent for lead anti-cancer product
24 February, 2010 by Staff WritersIssued patent for lead product PAT-CM1 provides protection through the year 2023.
MicroRNA causes "double whammy" of metastasis and angiogenesis in breast cancer
23 February, 2010 by Tim DeanNew research shows the microRNA, miR-9, plays a significant role in metastasis and blood vessel growth in breast cancer and could provide a target for future therapies.
Epigenetics makes cancer cell "lean mean machine"
22 February, 2010 by Tim DeanGarvan researchers find gene silencing in prostate cancer is more substantial than expected and could provide key to battling cancer.
Step forward in linking metals to Alzheimer’s disease
17 February, 2010 by Staff WritersStudy in mice finds significant role for zinc transport protein ZnT3 in the neurodegenerative disease.
Lorne special: Sleuthing oncogenes
16 February, 2010 by Graeme O'NeillTom Gonda’s research team at the Diamantina Institute in Brisbane is using new technology to unmask the proto-oncogenes that can cause cancer in mutant form.
Lorne special: Piecing together the breast cancer puzzle
15 February, 2010 by Fiona WylieJust when things seemed to be going around in circles, some quite unexpected data from WEHI has opened up an exciting new avenue in breast cancer research.
Lorne special: Mortality, metastasis and miRNAs
12 February, 2010 by Graeme O'NeillGreg Goodall’s Adelaide research group has explored found tantalising links between the miR-200 gene family and metastasis in a wide range of cancers.
Lorne special: Dynamic dynamin and synaptic transmission
09 February, 2010 by Fiona WylieDynamin-1, plays a key role in the endocytosis at the synapse and the activity of neurotransmitters. Professor Phil Robinson is revealing the behaviour of this pivotal protein and its role in diseases like epilepsy.
